Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05310097 · ClinicalTrials.gov registry record · NA

Cognitive Processing Therapy (CPT) Memory Support (MS) Study

A NA study of PTSD, sponsored by Boston University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05310097: Recruiting NA study of PTSD, sponsored by Boston University.

NCT05310097 is a NA study of PTSD that is actively recruiting participants, run by Boston University. The registered enrollment target is 100 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05310097, a NA study of PTSD, is actively recruiting participants, sponsored by Boston University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The efficacy of psychological interventions for posttraumatic stress disorder (PTSD) is likely limited by the difficulty participants have learning and remembering important therapy content. Accordingly, the present study will examine the utility of integrating a Memory Support (MS) intervention into Cognitive Processing Therapy (CPT), an empirically supported and widely disseminated treatment for PTSD. MS was designed to integrate techniques aimed at facilitating encoding, consolidation, and retrieval of new learning into existing treatments, and has been shown to improve outcomes when integrated into cognitive therapy for depression. A pilot randomized controlled trial (n=52) comparing CPT with Memory Support (CPT+MS) to CPT-alone will be conducted. Study participants will be adults diagnosed with PTSD. The primary aim of the trial will be to determine if CPT+MS will lead to greater memory and learning of therapy content relative to CPT-alone, and to establish the acceptability and feasibility of integrating MS into CPT. Secondary aims include a preliminary examination of treatment efficacy, as indicated by the magnitude of changes in PTSD symptoms between conditions, and target validation, as indicated by associations between memory and learning of therapy content and treatment response. Exploratory analyses will examine several indicators of baseline memory-related cognitive functioning as predictors of memory and learning of therapy content, providing preliminary data to inform future research on personalized application of MS. Results of the trial will advance scientific knowledge about methods for optimizing memory and learning as a mechanism for improving PTSD treatment outcomes.

Primary Outcome

The Therapy Recall Task involves participants writing down as many distinct "treatment points" as they can in a 10-minute period. Treatment points are defined as insights, skills, or strategies they think are important to remember or implement as part of their therapy. Responses are scored based on the number of distinct treatment points described.

Conditions Studied

Interventions

  • BEHAVIORAL CPT
  • BEHAVIORAL MS

Study Locations (1)

Massachusetts

  • VA Boston Healthcare System - Jamaica Plain

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-01-04
Est. Completion 2027-04
Phase NA
Boston University

185 total trials

What NCT05310097 shows while recruiting

NCT05310097 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (67% lower).

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which CPT is the first listed.

NCT05310097 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05310097 about?

NCT05310097 is a clinical study titled "Cognitive Processing Therapy (CPT) Memory Support (MS) Study". The efficacy of psychological interventions for posttraumatic stress disorder (PTSD) is likely limited by the difficulty participants have learning and remembering important therapy content. Accordingly, the present study will examine the utility of integrating a Memory Support (MS) intervention int...

What is the current status of trial NCT05310097?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-01-04. Estimated completion is 2027-04.

What conditions does trial NCT05310097 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT05310097?

The interventions under investigation include: CPT (BEHAVIORAL), MS (BEHAVIORAL).

Who is sponsoring clinical trial NCT05310097?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05310097 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05310097's enrollment target sits among peer trials

100 62nd of 154 higher than 89 of 154 other PTSD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05310097, the US trial registry maintained by the National Library of Medicine. NCT05310097 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.